Intuitive Corp (ISRG): Rasio kapitalisasi pasar marang pendapatan

Simbol lan logo merek Intuitive Surgical Inc (ISRG)

Is it worth investing in Intuitive Surgical (ISRG), given the strict sanitary requirements for transporting medical technology? The historical P/S trend helps assess the risk of overpayment, and 13.20 expresses the current value of this metric. The business relies on the da Vinci system and the sale of consumables. A diversified warehouse network and component quality control guarantee assembly stability.

Rasio rega marang pendapatan: Intuitive (ISRG) kanggo 04.07.2022 - 13.11.2026

Rincian metrik lan analitis perusahaan Intuitive Surgical Inc (ISRG)

- kuotasi lan prakiraan analis:
Ringkesan analitik perusahaan:intuitive.com
Produk seri intuitive.com

Intuitive Surgical (ISRG) dominance in the robotic surgery segment via Da Vinci systems allows the market to price in a high premium for every unit of revenue generated. By analyzing the revenue multiple trend, an investor assesses the ratio of market capitalization to total sales, which enables the rapid identification of business overvaluation or hidden cash flow stagnation without waiting for quarterly reports.

Pesaing Intuitive Surgical

Kapitalisasi marang volume dodolan DHR|Rasio rega marang pendapatan Becton Dickinson BDX|Rasio kapitalisasi pasar marang pendapatan STE|WST: Kapitalisasi marang pendapatan|BAX - Multiplikator P/S|Masimo Corporation (MASI) - Rasio rega marang pendapatan|Kapitalisasi marang pendapatan stevanatogroup.com|TFX (Teleflex) - Multiplikator P/S|Rega marang dodolan Merit Medical Systems, Inc. MMSI|Rasio rega marang pendapatan Envista Holdings Corp (NVST)|ICU Medical Inc. - Rasio kapitalisasi marang pendapatan|DENTSPLY SIRONA Inc. - Kapitalisasi marang pendapatan|Kapitalisasi marang volume dodolan LMAT (lemaitre.com)|ATRC - Rasio rega marang pendapatan|Koefisien rega marang pendapatan STAAR Surgical Co. STAA|NAGE: Multiplikator P/S|ZIMV - Koefisien rega marang pendapatan|Rasio rega marang pendapatan AngioDynamics, Inc.|Rasio kapitalisasi marang pendapatan CERS (cerus.com)|Kapitalisasi marang pendapatan TKNO (Teknova)|Kapitalisasi marang volume dodolan MGRM|Sharps Technology - Kapitalisasi marang pendapatan|Multiplikator P/S InfuSystem INFU|Utah Medical Products - Multiplikator P/S|Koefisien rega marang pendapatan KORU Medical Systems KRMD|NYXH (Nyxoah) - Kapitalisasi marang pendapatan|MBOT: Kapitalisasi marang volume dodolan|PDEX (Pro-Dex Corp) - Multiplikator P/S|Zentek Corp (ZTEK) - Koefisien rega marang pendapatan|Kapitalisasi marang pendapatan ELUT (Elutia Inc.)|Rasio rega marang pendapatan MLSS (milestonescientific.com)|Multiplikator P/S NXGL (NEXGEL)|Retractable Technologies Inc. (RVP) - Rega marang dodolan|HBIO: Kapitalisasi marang pendapatan|Rasio kapitalisasi pasar marang pendapatan FEMY (Femasys Corporation)|meihuamed.com (MHUA) - Rasio rega marang pendapatan|POAI - Koefisien rega marang pendapatan|Kapitalisasi marang pendapatan CJMB|Multiplikator P/S Atrion Corp.|Rasio rega marang pendapatan NeuroMetrix Corp (NURO)